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The danger of syphilitic infection to the fetus in utero, regard-
less of whether the maternal syphilis is active or latent, is well
known. Indeed, re-treatment throughout the period of gestation is
advised by the Cooperative Clinical Group8 even when the mother
has received adequate antisyphilitic therapy prior to pregnancy and
presents no serological or clinical evidence of this disease when she
is first seen in her pregnancy. Consequently, the question of whether
or not re-treatment is necessary in those patients who have
become pregnant subsequent to receiving massive dose arsenotherapy
by the constant intravenous-drip procedure of Hyman-and his asso-
ciates" 6 is an important one.
It is the purpose of this short communication to relate the case
histories and to describe the outcome of the infants of two patients
who had received massive dose arsenotherapy for early syphilis a
short time before the onset of pregnancy. In this paper are also
included reports upon the administration of this form of therapy
in two patients whose pregnancy was complicated by secondary
syphilis.
Method
Clinical material and methods have been fullydescribed in earlier
communications5' 1 from this clinic. In brief, the particular method
of massive dose arsenotherapy employed is that of Hyman, Chargin,
andLeifer" 6 in which 240 mg. of Mapharsen are administered daily
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over a 12-hour period by a continuous intravenous drip. This pro-
cedure is carried on for 5 days, the patient thus receiving a total
of 1.20 gm. of Mapharsen during the 5-day period.
Case Reports
CASE 1. B. B.: The patient was a 21-year-old unmarried negress,
admitted with secondary syphilis, dark-field positive, of 6 weeks duration.
Kahn and Wassermann reactions were positive. Five days after a single intra-
muscular dose of 0.2 gm. of bismuth subsalicylate, massive dose arsenotherapy
by the intravenous-drip method was given, the patient receiving 1.20 gm. of
Mapharsen in 5 days. Nausea and vomiting were moderate (12x) and there
was a secondary fever reaching as high as 103.00 with a diffuse erythema on
the two days following therapy. Convalescence was uneventful. The sub-
sequent clinical data are detailed in Table 1.
Sero-reversal took place 9 weeks after treatment, the patient having
become pregnant shortly before this time, presumably about the 8th week.
No further antisyphilitic therapy was administered during the period of gesta-
tion, since close observation revealed the patient to be clinically and sero-
logically free of syphilis.
Forty-seven weeks after therapy, the patient was delivered spontaneously
of a normal, full-term, male infant weighing 3625 gm. The placenta
weighed 675 gm. and revealed no gross or microscopic evidence of syphilis.
Kahn and Wassermann reactions on the cord blood were negative. There
were no stigmata of congenital syphilis. During the next 24 weeks no
clinical, serological, or roentgenological evidence of syphilis developed. With
the exception of a fairly severe seborrheic dermatitis, the child gained and
developed normally, always appearing to be in good health. Specific data of
the follow-up study are presented in Table 1.
CASE 2. I. R.: The patient, a 19-year-old unmarried negress, was
admitted to the hospital with a chancre of the gum of 4 weeks duration.
Because of the great rarity of this type of primary lesion, this case has been
reported elsewhere,'0 together with a Kodachrome picture of the chancre.
The Kahn and Wassermann reactions were positive. Two days after a
single intramuscular dose of 0.2 gm. of bismuth subsalicylate, massive dose
arsenotherapy was administered, the patient receiving a total of 1.20 gm. of
Mapharsen over the 5-day period. Vomiting was severe (54x) and prolonged
over the 5-day period with the development of a gastro-enteritis of short
duration. On the last day of therapy, a severe thrombophlebitis developed,
lasting 3 days and accompanied by chills and a temperature as high as
105.20 F. A secondary anemia with hemoglobin concentration dropping
from 75 to 58 per cent was manifest 2 weeks after treatment. This anemia
was of short duration. Details of the serological changes during the follow-up
period are recorded in Table 2.
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TABLE 1
.CLINICAL) SEROLOGICAL, AND ROENTGENOLOGICAL DATA IN CASE I-B. B.
AND INFANT
Mother Infant
Period Serology Serology Physical
after Wasser- Remarks Age Wasser- exami- Remarks
therapy Kahn mann Kahn mann nation
0
4 wks.
6Y2 "
9 "
14 "
18 "
29 "
40 "
41 "
43 "c
46 "
47 "
+
+
60 wks.I
+
* Cord blood.
5-day
therapy
Last men-
strual
period
Cerebro-
spinal
fluid
normal
Birth
7 da.
10 da.
24 da.
5 wks.
7 wks.
9 wks.
14 wks.
20 wks.
24wks.
*
- Normal
Normal
Normal
Seborrhea
ofscalp
Seborrhea
Seborrhea
Skin clear
Normal
Normal
Wgt. 3625
gm.
Long bone
x-rays
normal
Longbone
x-rays
normal
Wgt. 7670
gm.368 YALE JOURNAL OF BIOLOGY AND MEDICINE
TABLE 2
CLINICAL, SEROLOGICAL, AND ROENTGENOLOGICAL DATA IN CASE 2-I. R.
AND INFANT
Mother Infam
Period Serology Serology physical
after Wasser- Remarks Age Wasser- exami- Remarks
therapy Kahn man Kahn man nation
1~~~ .~
0
4 wks.
7 "
9
CC
12Y/2 cc
14 "
18 "
19 "
20 "
24 "
26 "
34 'c
40 "
50 "
53 "
54
56
71
79
+
+
+
+
* Cord blood.
+
+
+
5-day
therapy
Last men-
strual
period
Cerebro-
spinal fl.
normal
Birth
I wk.
3 wks.
18 wks.
26 wks.
* * Normal
Normal
Normal
Normal
Normal
Wgt. 3565
gm.
Long bone
x-rays
normal
Wgt. 8180
gm.
The Wassermann reaction returned to negative 9 weeks after treatment
although complete sero-reversal was not achieved until the 19th week. Well
before this time, however, the patient became pregnant, the last menstrual
period occurring 123/2 weeks after therapy, or 4y2 weeks before sero-reversal.MASSIVE ARSENOTHERAPY AND PREGNANCY
As in the previous case described, the serology remained negative and, con-
sequently, no further antisyphilitic therapy was given.
Fifty-three weeks after treatment, the patient was delivered by low
forceps of a normal, full-term, male infant weighing 3565 gm. The placenta
weighed 535 gm. and revealed no gross or microscopic evidences of syphilis.
Kahn and Wassermann reactions on the cord blood were negative. Physical
examination of the infant soon after birth revealed no abnormalities suggestive
of congenital syphilis and during the follow-up period of 26 weeks has gained
well and revealed evidence of normal physical and mental development.
Details are recorded in Table 2.
The two following cases are recorded with brevity since the
patients are still in the gestational period. The reports serve only
to suggest the fact that massive dose arsenotherapy may be given to
patients during the early period of pregnancy.
CASE 3. M. G.: A 31-year-old white female, admitted with recent
history of secondary syphilis, Kahn and Wassermann positive, pregnancy of 5
weeks duration. Treatment with massive arsenotherapy produced 1) a mild
Herxheimer reaction with generalized maculo-papular eruption; 2) severe
(50x) and prolonged vomiting. In follow-up period, mild numbness and
tingling of feet developed at the 2nd week. No anemia developed. Remains
sero-positive up to present period, 19 weeks after treatment.
CASE 4. M. R.: A 20-year-old unmarried negress, admitted with recent
history of secondary syphilis, Kahn and Wassermann positive, duration of
pregnancy 14 weeks. Received massive dose arsenotherapy with the only
toxic manilfestations being mild nausea and vomiting (Sx). Patient remains
sero-positive up to present, 5 weeks after treatment. No anemia developed
in follow-up period.
Discussion
Under careful observation two infants, each born of a mother
who very shortly before the onset of pregnancy received massive dose
arsenotherapy for early syphilis, have developed normally and have
never shown signs of congenital syphilis. Moreover, in neither
mother had sero-reversal taken place before conception but despite
this fact the fetuses developed normally to full term. Complete
serological examinations ofthebloodofeach infant from birth until 6
months of age have been consistently negative for syphilis; likewise,
no roentgenological or clinical evidence of syphilis has developed,
and it seems most improbable that this disease will develop
in the future in either of these children. The development of con-
genital syphilis after the age of 6 months in an infant who has been
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found at that age to be free of stigmata and who presents a negative
serology is said to be very rare indeed2' ' 7' ' and in our experience
has never occurred.
From the experience gained in the last two case histories pre-
sented (Case 3-M. G. and Case 4-M. R.), it would appear that
the complication of syphilis by pregnancy presents no serious contra-
indication for treatment of early syphilis by massive dose arseno-
therapy. In neither of these cases was there observed any toxic
manifestation of arsenic other than those seen in the treatment of
non-pregnant patients.
It must be realized, however, that the problem of treatment by
massive arsenotherapy in relation to the effect on and the outcome
of the fetus remains unanswered for the present. It is our plan to
followthese patients carefully and, if sero-reversal takes place before
the 28th to 32nd week of gestation, to withhold the use of further
antisyphilitic therapy. On the other hand, if these patients are sero-
resistant or perchance recurrence takes place, it is obvious that inten-
sive treatment with one of the arsenicals is indicated.
Summary
1. The case histories are described of two females who had
received massive dose arsenotherapy for early syphilis shordy before
the onset of pregnancy. In both instances these patients were deliv-
ered of normal, full-term infants, neither of which developed clini-
cal, serological, or roentgenological evidences of congenital syphilis
during a 6 months follow-up period.
2. The treatment by means of massive dose arsenotherapy of
two additional pregnant patients with secondary syphilis is described.
The course of therapy in each instance was uneventful. Neither
patient has delivered; consequently no data are available concerning
the fetus.
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ADDENDUM
The authors are indebted to Dr. Barbara Arthur and Dr. Edith MacLeod, Staff
Physicians at the State Farm for Women, Niantic, Conn., for aid in the follow-up of
Case 2-I. R. and her infant.